Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation

Forbion European Acquisition Corp. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 SC 13G Sculptor Capital LP reports a 9.8% stake in Forbion European Acquisition Corp.
10/06/2023 SC 13G Feis Lawrence reports a 7.8% stake in Forbion European Acquisition Corp.
07/28/2023 425 Form 425 - Prospectuses and communications, business combinations:
07/28/2023 8-K Investor presentation
Docs: "Presentation entitled “Development of a Non-Viral Gene Therapy Platform for Mucosal Tissues”",
"Presentation entitled “Development of a Non-Viral Gene Therapy Platform for Mucosal Tissues”"
06/06/2023 425 Form 425 - Prospectuses and communications, business combinations:
06/06/2023 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial ...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Working Capital Promissory Note dated June 6, 2023, issued by Forbion European Acquisition Corp. to Forbion Growth Sponsor FEAC I B.V",
"Extension Promissory Note dated June 6, 2023, issued by Forbion European Acquisition Corp. to Forbion Growth Sponsor FEAC I B.V"
05/17/2023 425 Form 425 - Prospectuses and communications, business combinations:
05/17/2023 8-K Investor presentation
Docs: "enGene, Inc. and Forbion European Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biotechnology Company Developing Next-Generation Non-Viral, Locally Administered Gene Therapies",
"Investor Presentation"
03/24/2023 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial ...
Docs: "Promissory Note dated March 24, 2023, issued by Forbion European Acquisition Corp. to Forbion Growth Sponsor FEAC I B.V",
"Promissory Note dated March 24, 2023, issued by Forbion European Acquisition Corp. to Forbion Growth Sponsor FEAC I B.V"
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/02/2023 SC 13G HIGHBRIDGE CAPITAL MANAGEMENT LLC reports a 7.1% stake in Forbion European Acquisition Corp.
01/19/2023 10-Q/A Quarterly Report for the period ended September 30, 2022 [amend]
01/19/2023 10-Q/A Quarterly Report for the period ended June 30, 2022 [amend]
01/19/2023 10-Q/A Quarterly Report for the period ended March 31, 2022 [amend]
01/19/2023 10-Q/A Quarterly Report for the period ended September 30, 2021 [amend]
08/11/2022 10-Q Quarterly Report for the period ended June 30, 2022
05/13/2022 10-Q Quarterly Report for the period ended March 31, 2022
04/14/2022 10-K Annual Report for the period ended December 31, 2021
03/30/2022 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
03/18/2022 3/A Forbion Growth Sponsor FEAC I B.V. (10% Owner) has filed a Form 3/A on Forbion European Acquisition Corp.
02/14/2022 SC 13D Forbion Growth Sponsor FEAC I B.V. reports a 32.7% stake in FORBION EUROPEAN ACQUISITION CORP.
02/14/2022 SC 13G/A CITADEL ADVISORS LLC reports a 7.4% stake in Forbion European Acquisition Corp.
02/08/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/01/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Forbion European Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants Commencing February 1, 2022 Naarden, The Netherlands, February 1, 2022 - Forbion European Acquisition Corp. today announced that, commencing February 1, 2022, holders of the units sold in the Company's initial public offering of 12,650,000 units completed on December 15, 2021, including the 1,650,000 units sold pursuant to the exercise of the underwriters' over-allotment option, may elect to separately trade the shares of Class A common stock and warrants included in the units. Shares of Class A common stock and warrants that are separated will trade on the Nasdaq Global Market under the symbols “FRBN” and “FRBNW,” respectively. Those units not separated will continue to trade on the ..."
01/24/2022 10-Q Quarterly Report for the period ended September 30, 2021
12/27/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
12/20/2021 8-K Other Events, Financial Statements and Exhibits
Docs: "Audited Balance Sheet, as of December 14, 2021"
12/20/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
12/15/2021 8-K Quarterly results
12/14/2021 8-K Quarterly results
12/13/2021 424B4 Form 424B4 - Prospectus [Rule 424(b)(4)]:
12/10/2021 EFFECT Form EFFECT - Notice of Effectiveness:
12/09/2021 S-1MEF Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]:
12/09/2021 3 Joustra Wouter (Director) has filed a Form 3 on Forbion European Acquisition Corp.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy